Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
07/29/2014 | US8791063 Shortened tetranectin-apolipoprotein A-I fusion protein, a lipid particle containing it, and uses thereof |
07/29/2014 | US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
07/29/2014 | US8791060 Composition and use of phyto-percolate for treatment of disease |
07/29/2014 | US8790933 Screening |
07/29/2014 | US8790897 Treatment of mucus hypersecretion |
07/29/2014 | US8790895 Generation of artificial binding proteins on the basis of ubiquitin proteins |
07/29/2014 | US8790883 Methods of identifying NF-κB inhibitors |
07/29/2014 | US8790663 Antigenic determinants of human death receptor DR5 |
07/29/2014 | US8790661 Exosomes derived from reticulocytes infected with Plasmodium sp., method for obtaining them and uses thereof |
07/29/2014 | US8790656 PRRSV vaccines |
07/29/2014 | US8790653 Peptide inhibitors for mediating stress responses |
07/29/2014 | US8790636 Human skin equivalents expressing exogenous polypeptides |
07/29/2014 | US8790635 Live, oral vaccine for protection against Shigella dysenteriae serotype 1 |
07/29/2014 | CA2718812C Porcine adenovirus type 3 genome |
07/29/2014 | CA2697205C Peptidomimetic protease inhibitors |
07/29/2014 | CA2691033C Capsid proteins and uses therefore |
07/29/2014 | CA2685270C Expression vectors for stimulating an immune response and methods of using the same |
07/29/2014 | CA2589487C Means and methods for detecting methylated dna |
07/29/2014 | CA2570812C Brassica indehiscent1 sequences |
07/29/2014 | CA2568781C Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases |
07/29/2014 | CA2548896C Multimeric galectin-1 and its use for inducing il-10 production |
07/29/2014 | CA2537161C Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
07/29/2014 | CA2518669C Purification process |
07/29/2014 | CA2494974C Il-7 drug substance, composition, preparation and uses |
07/29/2014 | CA2489052C Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions |
07/29/2014 | CA2463772C Thrombin-cleavable chimeric proteins |
07/29/2014 | CA2411304C Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
07/29/2014 | CA2310097C Novel exendin agonist compounds |
07/24/2014 | WO2014113802A1 TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS |
07/24/2014 | WO2014113759A1 Theragnostic particles |
07/24/2014 | WO2014113605A1 Proteins involved in plant stress response |
07/24/2014 | WO2014113585A1 Split peroxidases and methods of use |
07/24/2014 | WO2014113510A1 Rapid clearance of antigen complexes using novel antibodies |
07/24/2014 | WO2014113459A1 Hiv-1 neutralizing factor |
07/24/2014 | WO2014113436A1 Adenoviruses and their use |
07/24/2014 | WO2014111841A2 Peptide |
07/24/2014 | WO2014111840A2 Peptide |
07/24/2014 | WO2014111744A1 A soluble fibroblast growth factor receptor 3 (fgr3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders |
07/24/2014 | WO2014111733A1 Composition and uses thereof |
07/24/2014 | WO2014111546A1 Method for the identification of bitter tasting compounds and bitter taste modulating compounds |
07/24/2014 | WO2014111509A2 Peptides for enhancing protein expression |
07/24/2014 | WO2014111467A1 A soluble fibroblast growth factor receptor 3 (fgr3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders |
07/24/2014 | WO2014111207A1 Diagnosis of leishmania infection |
07/24/2014 | WO2014110675A1 Novel cell wall deconstruction enzymes of amorphotheca resinae, rhizomucor pusillus, and calcarisporiella thermophila, and uses thereof |
07/24/2014 | WO2014110628A1 Gene and mutations thereof associated with seizure disorders |
07/24/2014 | WO2014082042A3 Peptides that stimulate subcutaneous adipogenesis |
07/24/2014 | US20140208461 Defensin-encoding nucleic acid molecules derived from nicotiana alata, uses therefor and transgenic plants comprising same |
07/24/2014 | US20140206852 Signal-sensor polynucleotides |
07/24/2014 | US20140206851 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders isolated from brazilian biodiversity |
07/24/2014 | US20140206844 Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material |
07/24/2014 | US20140206843 Therapeutic TRAIL Fusion Protein and Preparation and Use Thereof |
07/24/2014 | US20140206836 Novel n- and c-terminal substituted antagonistic analogs of gh-rh |
07/24/2014 | US20140206758 Expression of il-12 family heterodimers |
07/24/2014 | US20140206748 Compositions and methods related to prostate cancer |
07/24/2014 | US20140206628 Polypeptides for treating and/or limiting influenza infection |
07/24/2014 | US20140206620 T cell receptors and related materials and methods of use |
07/24/2014 | US20140206619 Peptide for inducing regeneration of tissue and use thereof |
07/24/2014 | US20140206615 Glp-1 agonist and cardiovascular complications |
07/24/2014 | US20140206613 Methods to restore glycemic control |
07/24/2014 | US20140206609 Functionalized Exendin-4 Derivatives |
07/24/2014 | US20140206608 Exendin-4 Derivatives |
07/24/2014 | US20140206607 Glucagon/glp-1 receptor co-agonists |
07/24/2014 | US20140206603 Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
07/24/2014 | US20140206600 Charged lipoprotein complexes and their uses |
07/24/2014 | US20140206599 IL4/IL13 Binding Repeat Proteins and Uses |
07/24/2014 | US20140206598 Molecule for treating an inflammatory disorder |
07/24/2014 | US20140206576 Universal fibronectin type iii binding-domain libraries |
07/24/2014 | US20140206062 Recombinant Influenza Viruses for Vaccines and Gene Therapy |
07/24/2014 | US20140206021 Prion protein ligands and methods of use |
07/24/2014 | US20140206019 Fc-function assay |
07/24/2014 | US20140205993 Recombinant avian influenza vaccine and uses thereof |
07/24/2014 | US20140205839 Pure albumin and its method of preparation and detection |
07/24/2014 | US20140205629 Tc-83-derived alphavirus vectors, particles and methods |
07/24/2014 | US20140205625 Methods to increase antigenicity of membrane-bound polypeptides produced in plants |
07/24/2014 | US20140205624 Tetravalent and mixed head bivalent dengue vaccine |
07/24/2014 | US20140205621 Canine coronavirus vaccine |
07/24/2014 | US20140205619 Recombinant avian influenza vaccine and uses thereof |
07/24/2014 | US20140205600 Methods of promoting fat loss comprising administering an alk7 inhibitor |
07/24/2014 | US20140205588 Plasminogen and plasmin variants |
07/24/2014 | US20140205570 Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases |
07/24/2014 | US20140205568 Promyelocytic Leukemia Protein as a Redox Sensor |
07/24/2014 | US20140205560 Multimeric il-15 soluble fusion molecules and methods of making and using same |
07/24/2014 | DE112012003842T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
07/23/2014 | EP2757376A1 Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same |
07/23/2014 | EP2757373A1 Method for measuring anti-wt1 antibody |
07/23/2014 | EP2757153A1 Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor |
07/23/2014 | EP2757110A1 Novel alpha 1-antitrypsin variant, preparation method thereof, and use thereof |
07/23/2014 | EP2757109A2 HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
07/23/2014 | EP2757107A1 Method for solid phase synthesis of liraglutide |
07/23/2014 | EP2756850A1 Diagnosis of Leishmania infection |
07/23/2014 | EP2756765A1 Pharmaceutical compositions |
07/23/2014 | EP2756087A2 Non integrative chimeric lentiviral genomes as vaccines against hiv-1 |
07/23/2014 | EP2756077A1 Endoglycosidase from streptococcus pyogenes and methods using it |
07/23/2014 | EP2755997A1 T cell receptors recognizing hla-a1- or hla-cw7-restricted mage |
07/23/2014 | EP2755996A1 A novel method of isolation of tlr4 from cell lysates of monocular cells |
07/23/2014 | EP2755995A1 Increase in meiotic recombination in plants by inhibiting the fancm protein |
07/23/2014 | EP2755994A2 Escherichia coli vaccine combination |
07/23/2014 | EP2755993A1 Pseudomonas exotoxin a with less immunogenic b cell epitopes |
07/23/2014 | EP2755677A1 Anti-her2 vaccine based upon aav derived multimeric structures |
07/23/2014 | EP2755676A1 Composition and dressing for wound treatment |